MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

West Pharmaceutical Services Inc

Deschisă

SectorSănătate

275.58 -0.46

Rezumat

Modificarea prețului

24h

Curent

Minim

274.23

Maxim

276.46

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

40.83

88.032

Randament dividend

0.31

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+25.94% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.26%

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

60M

20B

Deschiderea anterioară

276.04

Închiderea anterioară

275.58

Sentimentul știrilor

By Acuity

34%

66%

88 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 dec. 2025, 22:20 UTC

Principalele dinamici ale pieței

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec. 2025, 17:31 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec. 2025, 16:30 UTC

Principalele dinamici ale pieței

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec. 2025, 15:19 UTC

Principalele dinamici ale pieței

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec. 2025, 15:17 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec. 2025, 14:37 UTC

Principalele dinamici ale pieței

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 dec. 2025, 21:13 UTC

Achiziții, Fuziuni, Preluări

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec. 2025, 17:16 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 dec. 2025, 17:00 UTC

Achiziții, Fuziuni, Preluări

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec. 2025, 15:57 UTC

Achiziții, Fuziuni, Preluări

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec. 2025, 15:02 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec. 2025, 14:40 UTC

Achiziții, Fuziuni, Preluări

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 dec. 2025, 13:01 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 dec. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 dec. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 dec. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 dec. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 dec. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

25.94% sus

Prognoză pe 12 luni

Medie 348.7 USD  25.94%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

88 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat